Cargando…

Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures

[Image: see text] The impact of the chain length or dispersity of polymers in controlling the crystallization of amorphous active pharmaceutical ingredients (APIs) has been discussed for a long time. However, because of the weak control of these parameters in the majority of macromolecules used in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Minecka, Aldona, Tarnacka, Magdalena, Jurkiewicz, Karolina, Hachuła, Barbara, Wrzalik, Roman, Kamiński, Kamil, Paluch, Marian, Kamińska, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872431/
https://www.ncbi.nlm.nih.gov/pubmed/33355470
http://dx.doi.org/10.1021/acs.molpharmaceut.0c00982
_version_ 1783649184344178688
author Minecka, Aldona
Tarnacka, Magdalena
Jurkiewicz, Karolina
Hachuła, Barbara
Wrzalik, Roman
Kamiński, Kamil
Paluch, Marian
Kamińska, Ewa
author_facet Minecka, Aldona
Tarnacka, Magdalena
Jurkiewicz, Karolina
Hachuła, Barbara
Wrzalik, Roman
Kamiński, Kamil
Paluch, Marian
Kamińska, Ewa
author_sort Minecka, Aldona
collection PubMed
description [Image: see text] The impact of the chain length or dispersity of polymers in controlling the crystallization of amorphous active pharmaceutical ingredients (APIs) has been discussed for a long time. However, because of the weak control of these parameters in the majority of macromolecules used in pharmaceutical formulations, the abovementioned topic is poorly understood. Herein, four acetylated oligosaccharides, maltose (acMAL), raffinose (acRAF), stachyose (acSTA), and α-cyclodextrin (ac-α-CD) of growing chain lengths and different topologies (linear vs cyclic), mimicking the growing backbone of the polymer, were selected to probe the influence of these structural factors on the crystallization of naproxen (NAP)—an API that does not vitrify regardless of the cooling rate applied in our experiment. It was found that in equimolar systems composed of NAP and linear acetylated oligosaccharides, the progress and activation barrier for crystallization are dependent on the molecular weight of the excipient despite the fact that results of Fourier transform infrared studies indicated that there is no difference in the interaction pattern between measured samples. On the other hand, complementary dielectric, calorimetric, and X-ray diffraction data clearly demonstrated that NAP mixed with ac-α-CD (cyclic saccharide) does not tend to crystallize even in the system with a much higher content of APIs. To explain this interesting finding, we have carried out further density functional theory computations, which revealed that incorporation of NAP into the cavity of ac-α-CD is hardly possible because this state is of much higher energy (up to 80 kJ/mol) with respect to the one where the API is located outside of the saccharide torus. Hence, although at the moment, it is very difficult to explain the much stronger impact of the cyclic saccharide on the suppression of crystallization and enhanced stability of NAP with respect to the linear carbohydrates, our studies clearly showed that the chain length and the topology of the excipient play a significant role in controlling the crystallization of this API.
format Online
Article
Text
id pubmed-7872431
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-78724312021-02-10 Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures Minecka, Aldona Tarnacka, Magdalena Jurkiewicz, Karolina Hachuła, Barbara Wrzalik, Roman Kamiński, Kamil Paluch, Marian Kamińska, Ewa Mol Pharm [Image: see text] The impact of the chain length or dispersity of polymers in controlling the crystallization of amorphous active pharmaceutical ingredients (APIs) has been discussed for a long time. However, because of the weak control of these parameters in the majority of macromolecules used in pharmaceutical formulations, the abovementioned topic is poorly understood. Herein, four acetylated oligosaccharides, maltose (acMAL), raffinose (acRAF), stachyose (acSTA), and α-cyclodextrin (ac-α-CD) of growing chain lengths and different topologies (linear vs cyclic), mimicking the growing backbone of the polymer, were selected to probe the influence of these structural factors on the crystallization of naproxen (NAP)—an API that does not vitrify regardless of the cooling rate applied in our experiment. It was found that in equimolar systems composed of NAP and linear acetylated oligosaccharides, the progress and activation barrier for crystallization are dependent on the molecular weight of the excipient despite the fact that results of Fourier transform infrared studies indicated that there is no difference in the interaction pattern between measured samples. On the other hand, complementary dielectric, calorimetric, and X-ray diffraction data clearly demonstrated that NAP mixed with ac-α-CD (cyclic saccharide) does not tend to crystallize even in the system with a much higher content of APIs. To explain this interesting finding, we have carried out further density functional theory computations, which revealed that incorporation of NAP into the cavity of ac-α-CD is hardly possible because this state is of much higher energy (up to 80 kJ/mol) with respect to the one where the API is located outside of the saccharide torus. Hence, although at the moment, it is very difficult to explain the much stronger impact of the cyclic saccharide on the suppression of crystallization and enhanced stability of NAP with respect to the linear carbohydrates, our studies clearly showed that the chain length and the topology of the excipient play a significant role in controlling the crystallization of this API. American Chemical Society 2020-12-23 2021-01-04 /pmc/articles/PMC7872431/ /pubmed/33355470 http://dx.doi.org/10.1021/acs.molpharmaceut.0c00982 Text en © 2020 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Minecka, Aldona
Tarnacka, Magdalena
Jurkiewicz, Karolina
Hachuła, Barbara
Wrzalik, Roman
Kamiński, Kamil
Paluch, Marian
Kamińska, Ewa
Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures
title Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures
title_full Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures
title_fullStr Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures
title_full_unstemmed Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures
title_short Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures
title_sort impact of the chain length and topology of the acetylated oligosaccharide on the crystallization tendency of naproxen from amorphous binary mixtures
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872431/
https://www.ncbi.nlm.nih.gov/pubmed/33355470
http://dx.doi.org/10.1021/acs.molpharmaceut.0c00982
work_keys_str_mv AT mineckaaldona impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures
AT tarnackamagdalena impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures
AT jurkiewiczkarolina impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures
AT hachułabarbara impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures
AT wrzalikroman impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures
AT kaminskikamil impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures
AT paluchmarian impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures
AT kaminskaewa impactofthechainlengthandtopologyoftheacetylatedoligosaccharideonthecrystallizationtendencyofnaproxenfromamorphousbinarymixtures